GSK spins off $36 billion consumer-healthcare business Haleon

The new stand-alone company, called Haleon PLC, fetched a market value of about £30.5 billion, equivalent to $36.4 billion, at its stock-market debut MondayPremium
The new stand-alone company, called Haleon PLC, fetched a market value of about £30.5 billion, equivalent to $36.4 billion, at its stock-market debut Monday
 wsj 4 min read . Updated: 18 Jul 2022, 07:10 PM IST Denise Roland, The Wall Street Journal

Pharmaceutical giant sheds toothpaste-to-painkillers arm to sharpen focus on drugs and vaccines

GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant.

Close